Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ADMA Biologics Investigated for Securities Fraud over Culper Research Report Revelation – Investors with Losses Urged to Contact BFA Law
-
ADMA Biologics Faces Securities Fraud Investigation after Culper Research Revelation Leads to 29% Stock Drop – BFA Law Notifies Investors to Act
-
Neion Bio exits stealth with first biosimilar co-development and supply partnership, leveraging its genetic engineering platform to enable scalable, lower-
-
ALBANY, N.Y., March 19, 2026 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK...
-
Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac
-
AI, healthcare technology, and digital infrastructure is a central theme dominating markets: the rapid convergence of AI with data-heavy industries
-
Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
-
The Stock Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets
-
Totaligent (OTCID: TGNT) signed a binding LOI with GloMed Solutions, a Japanese medical aesthetics and biologics distribution company
-
SAN FRANCISCO and LOS ANGELES and KIGALI, Rwanda, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical...